IMMP:NASDAQImmutep Limited analysis

The moving-average structure behind Immutep Limited is bearish at $0.3311, with short-term averages lagging the long-term ones. The last 30 days have lost 13.2%. With RSI at 36.5 the momentum picture is approaching oversold, alongside a bearish MACD signal. Price has been bracketed by support at $0.3200 and resistance at $0.4100.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. Analyst price targets sit 353.0% above the current price. Revenue is growing at 633.5%.
The composite risk read is 9/10, putting it in high territory. With 30-day volatility of 64.5%, a beta of 1.21 and a maximum drawdown of 90.3%, position sizing matters more than entry timing here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 91 on the fear-greed composite.
The horizons diverge: sell near-term but hold on a long view, at 1/10 conviction over the longer horizon.